cetylpyridinium chloride anhydrous has been researched along with rifampin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakhtyari, A; Hargreaves, JA; Jones, HK; Mackey, A; McCormick, AD; Millar, A; Morris, T; Oliver, SD; Slamon, D; Swaisland, HC; Taboada, MT | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and rifampin
Article | Year |
---|---|
In vitro metabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Demography; Drug Evaluation, Preclinical; Drug Interactions; Endothelin A Receptor Antagonists; Female; Health; Humans; Itraconazole; Male; Middle Aged; Oxygenases; Pyrrolidines; Rifampin | 2009 |